z-logo
open-access-imgOpen Access
High -catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression
Author(s) -
Jian-Nan Zhang,
Kai Huang,
Zhu Shi,
Jian Zou,
Yingwei Wang,
Zhanjun Jia,
Jianhua Zhang,
Lei Han,
Xin Yue,
Ning Liu,
Tao Jiang,
Yibing You,
Peng Pu,
Chunsheng Kang
Publication year - 2011
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/nor034
Subject(s) - carcinogenesis , akt2 , catenin , cancer research , chromatin immunoprecipitation , glioma , tumor progression , beta catenin , cell growth , signal transduction , biology , in vivo , chemistry , microbiology and biotechnology , gene expression , gene , wnt signaling pathway , promoter , akt1 , protein kinase b , genetics
Recent data suggest that the β-catenin/Tcf-4 signaling pathway plays an important role in human cancer tumorigenesis. However, the mechanism of β-catenin/Tcf-4 signaling in tumorigenesis is poorly understood. In this study, we show that Tcf-4 protein levels were significantly elevated in high-grade gliomas in comparison with low-grade gliomas and that Tcf-4 levels correlated with levels of AKT2. Reduction of β-catenin/Tcf-4 activity inhibited glioma cell proliferation and invasion in vitro and tumor growth in vivo. This effect of β-catenin/Tcf-4 activity was mediated by AKT2, and in vivo binding of β-catenin/Tcf-4 to the AKT2 promoter was validated using the chromatin immunoprecipitation assay and luciferase reporter assays. Taken together, we have demonstrated that Tcf-4 is associated with glioma progression and that AKT2 is a new member of the genes that are regulated by β-catenin/Tcf-4.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom